AvKARE
23 federal recalls on file, showing the 3 from the last 12 months. We monitor every CPSC, FDA, USDA, and NHTSA notice for AvKARE and translate it into plain English — free weekly digest, optional same-day alerts.
- 2026-03-04FDA-DrugClass IIStop using AvKARE Amantadine HCl capsules
AvKARE is recalling one lot of Amantadine HCl 100 mg capsules because they failed to meet dissolution specifications—meaning the capsules may not break down properly in the body, affecting how much medicine you receive. This is a quality issue identified during manufacturing testing. No injuries have been reported.
- 2026-01-14FDA-DrugClass IIStop using AvKARE Rosuvastatin 10 mg tablets
AvKARE is recalling Rosuvastatin 10 mg tablets (Lot #49124, expiring 12/31/2026) because they don't dissolve properly in the body. This means the medication may not work as intended. No injuries have been reported so far.
- 2025-10-15FDA-DrugClass IINorgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
Failed Content Uniformity Specifications
Get notified about new AvKARE recalls
Free weekly digest. We email when a new federal recall affects AvKARE or anything else in your household.
Get the Sunday Brief